Nelida Sjak-Shie

758 total citations
16 papers, 596 citations indexed

About

Nelida Sjak-Shie is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nelida Sjak-Shie has authored 16 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Nelida Sjak-Shie's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Nelida Sjak-Shie is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Nelida Sjak-Shie collaborates with scholars based in United States, Poland and China. Nelida Sjak-Shie's co-authors include Robert Vescio, James R. Berenson, Kimberly M. Parker, Malka Frantzen, Cibby Varkey Altamirano, Hans Mark, Evanthia T. Roussos Torres, Jeffrey M. Friedman, Mitesh J. Borad and Hank H. Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Brain Research.

In The Last Decade

Nelida Sjak-Shie

16 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nelida Sjak-Shie United States 12 367 295 244 115 88 16 596
Luhong Sun United States 10 286 0.8× 104 0.4× 213 0.9× 207 1.8× 127 1.4× 19 564
Leah J. Hogdal United States 12 412 1.1× 285 1.0× 236 1.0× 72 0.6× 203 2.3× 20 831
Pui K. Chan United States 12 629 1.7× 156 0.5× 157 0.6× 80 0.7× 65 0.7× 18 756
Justin Cidado United States 12 394 1.1× 91 0.3× 187 0.8× 64 0.6× 63 0.7× 36 561
Annalisa Rossini Italy 5 226 0.6× 180 0.6× 192 0.8× 25 0.2× 197 2.2× 8 499
Hans G. Drexler Germany 9 180 0.5× 133 0.5× 154 0.6× 150 1.3× 150 1.7× 11 485
Patricia Balsas Spain 10 290 0.8× 133 0.5× 153 0.6× 101 0.9× 81 0.9× 14 449
Heather Bendall United States 8 244 0.7× 126 0.4× 170 0.7× 184 1.6× 182 2.1× 14 628
Gökben Baskaynak Germany 9 169 0.5× 207 0.7× 145 0.6× 39 0.3× 58 0.7× 14 464
Piao Lo United States 6 269 0.7× 53 0.2× 163 0.7× 155 1.3× 149 1.7× 7 537

Countries citing papers authored by Nelida Sjak-Shie

Since Specialization
Citations

This map shows the geographic impact of Nelida Sjak-Shie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelida Sjak-Shie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelida Sjak-Shie more than expected).

Fields of papers citing papers by Nelida Sjak-Shie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelida Sjak-Shie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelida Sjak-Shie. The network helps show where Nelida Sjak-Shie may publish in the future.

Co-authorship network of co-authors of Nelida Sjak-Shie

This figure shows the co-authorship network connecting the top 25 collaborators of Nelida Sjak-Shie. A scholar is included among the top collaborators of Nelida Sjak-Shie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelida Sjak-Shie. Nelida Sjak-Shie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Foss, Francine M., Nelida Sjak-Shie, André Goy, Ranjana H. Advani, & Eric D. Jacobsen. (2010). Phase II study of denileukin diftitox with CHOP chemotherapy in newly-diagnosed PTCL: CONCEPT trial.. Journal of Clinical Oncology. 28(15_suppl). 8045–8045. 20 indexed citations
3.
Foss, Francine M., Nelida Sjak-Shie, André Goy, et al.. (2007). Denileukin Diftitox (ONTAK) Plus CHOP Chemotherapy in Patients with Peripheral T-Cell Lymphomas (PTCL), the CONCEPT Trial.. Blood. 110(11). 3449–3449. 13 indexed citations
4.
White, Leonard A., et al.. (2007). A phase II study of docetaxel (D) plus imatinib (I) in patients with previously treated non-small cell lung cancer. Journal of Clinical Oncology. 25(18_suppl). 18200–18200. 2 indexed citations
5.
Campbell, Richard A., Nelida Sjak-Shie, Haiming Chen, et al.. (2006). LAGλ-1: A clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. International Journal of Oncology. 28(6). 1409–17. 24 indexed citations
6.
Foss, Francine M., Nelida Sjak-Shie, André Goy, et al.. (2006). A Phase II Study of Denileukin Diftitox (Ontak®) with CHOP Chemotherapy in Patients with Newly-Diagnosed Aggressive T-Cell Lymphomas, the CONCEPT Trial: Interim Analysis.. Blood. 108(11). 2461–2461. 6 indexed citations
7.
Mark, Hans, Hank H. Yang, Kimberly M. Parker, et al.. (2003). The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.. PubMed. 9(3). 1136–44. 342 indexed citations
8.
Parker, Kimberly M., Hans Mark, Cibby Varkey Altamirano, et al.. (2002). Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma. Cancer Genetics and Cytogenetics. 137(1). 43–48. 30 indexed citations
9.
Sjak-Shie, Nelida, Robert Vescio, & James R. Berenson. (2000). Recent advances in multiple myeloma. Current Opinion in Hematology. 7(4). 241–246. 9 indexed citations
10.
Sjak-Shie, Nelida, et al.. (2000). The role of human and viral cytokines in the pathogenesis of multiple myeloma. Seminars in Cancer Biology. 10(5). 383–391. 16 indexed citations
11.
Pǒld, Mehis, et al.. (2000). Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Developmental & Comparative Immunology. 24(8). 719–731. 11 indexed citations
12.
Sjak-Shie, Nelida, Robert Vescio, Michael Kaminsky, et al.. (2000). Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.. PubMed. 6(11). 4226–33. 11 indexed citations
13.
Sjak-Shie, Nelida, Robert Vescio, & James R. Berenson. (1999). THE ROLE OF HUMAN HERPESVIRUS-8 IN THE PATHOGENESIS OF MULTIPLE MYELOMA. Hematology/Oncology Clinics of North America. 13(6). 1159–1167. 11 indexed citations
14.
Sjak-Shie, Nelida, Robert Vescio, & James R. Berenson. (1999). HHV-8 infection and multiple myeloma. Journal of Leukocyte Biology. 66(2). 357–360. 12 indexed citations
15.
Sjak-Shie, Nelida & Edwin M. Meyer. (1993). Effects of chronic nicotine and pilocarpine administration on neocortical neuronal density and [3H]GABA uptake in nucleus basalis lesioned rats. Brain Research. 624(1-2). 295–298. 16 indexed citations
16.
Lottenberg, Richard, Nelida Sjak-Shie, Asgerally T. Fazleabas, & R. Michael Roberts. (1988). Aprotinin inhibits urokinase but not tissue-type plasminogen activator. Thrombosis Research. 49(6). 549–556. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luhong Sun Breakdown of academic impact, for papers by Leah J. Hogdal Breakdown of academic impact, for papers by Pui K. Chan Breakdown of academic impact, for papers by Justin Cidado Breakdown of academic impact, for papers by Annalisa Rossini Breakdown of academic impact, for papers by Hans G. Drexler Breakdown of academic impact, for papers by Patricia Balsas Breakdown of academic impact, for papers by Heather Bendall Breakdown of academic impact, for papers by Gökben Baskaynak Breakdown of academic impact, for papers by Piao Lo
Rankless by CCL
2026